Literature DB >> 28971114

A Bench-Top In Vitro Wound Assay to Demonstrate the Effects of Platelet-Rich Plasma and Depleted Uranium on Dermal Fibroblast Migration.

Bronson I Pinto1, Aaron J Tabor1, Diane M Stearns2, Robert B Diller1, Robert S Kellar1,3,4.   

Abstract

Cellular migration assays are useful tools to investigate physiologic events on the bench top. Furthermore, this migration assay can be utilized to investigate wound healing therapeutics (those that encourage or accelerate wound closure) as well as deleterious agents (ones that mitigate or slow wound closure). The current study used an in vitro scratch assay to measure the effects of platelet-rich plasma (PRP) and depleted uranium (DU) in the form of uranyl acetate on cellular migration of human neonatal dermal fibroblasts in an in vitro simulation of wound healing. Data analyses included percent wound closure measured as the distance between cell margins, and rates of wound closure versus untreated controls. The highest doses of PRP (0.063, 0.125%) resulted in 50-65% wound closure after 4-8 hours relative to 38-44% in controls and the low-dose treatment group (0.031%). The high-dose treatments of PRP (0.125, 0.063%) reached 100% wound closure at 12 hours postwound versus 16 hours for controls and the low-dose treatment group (0.031%). Conversely, the higher doses of DU treatments (50 and 100 μM) resulted in <80% closure versus 100% closure in controls after 16 hours, with full closure observed at 20 hours. The highest dose of DU (1,000 μM) resulted in <20% closure versus 100% closure in controls after 16 hours. The use of the described scratch assay serves as a translatable bench-top model that has the potential to predict in vivo outcomes, and in many early studies can help to demonstrate proof-of-concept before moving into complex biological systems.

Entities:  

Keywords:  depleted uranium; in vitro; platelet-rich plasma; scratch assay; wound healing

Year:  2016        PMID: 28971114      PMCID: PMC5044976          DOI: 10.1089/aivt.2016.0001

Source DB:  PubMed          Journal:  Appl In Vitro Toxicol        ISSN: 2332-1512


  21 in total

1.  Role of wound healing myofibroblasts on re-epithelialization of human skin.

Authors:  V Moulin; F A Auger; D Garrel; L Germain
Journal:  Burns       Date:  2000-02       Impact factor: 2.744

Review 2.  Properties, use and health effects of depleted uranium (DU): a general overview.

Authors:  A Bleise; P R Danesi; W Burkart
Journal:  J Environ Radioact       Date:  2003       Impact factor: 2.674

3.  Increased proliferation in keloid fibroblasts wounded in vitro.

Authors:  M Calderon; W T Lawrence; A J Banes
Journal:  J Surg Res       Date:  1996-03       Impact factor: 2.192

4.  Significance of dermatologic findings in a cohort of depleted uranium-exposed veterans of Iraqi conflicts.

Authors:  Jessica Shiu; Joanna Gaitens; Katherine S Squibb; Patricia W Gucer; Melissa A McDiarmid; Anthony A Gaspari
Journal:  Dermatitis       Date:  2015 May-Jun       Impact factor: 4.845

5.  Optimum scratch assay condition to evaluate connective tissue growth factor expression for anti-scar therapy.

Authors:  Heekyung Moon; Hyeyoung Yong; Ae-Ri Cho Lee
Journal:  Arch Pharm Res       Date:  2012-02-28       Impact factor: 4.946

Review 6.  Research perspectives for pre-screening alternatives to animal experimentation: on the relevance of cytotoxicity measurements, barrier passage determinations and high throughput screening in vitro to select potentially hazardous compounds in large sets of chemicals.

Authors:  Erik Walum; Jan Hedander; Per Garberg
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

7.  Health effects of embedded depleted uranium.

Authors:  David E McClain; Kimberly A Benson; Tom K Dalton; John Ejnik; Christy A Emond; Shelly J Hodge; John F Kalinich; Michael R Landauer; David R Livengood; Alexandra C Miller; Terry C Pellmar; Michael D Stewart; Vilmar Villa; Jiaquan Xu
Journal:  Mil Med       Date:  2002-02       Impact factor: 1.437

8.  Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems.

Authors:  Satoshi Kushida; Natsuko Kakudo; Naoki Morimoto; Tomoya Hara; Takeshi Ogawa; Toshihito Mitsui; Kenji Kusumoto
Journal:  J Artif Organs       Date:  2014-04-20       Impact factor: 1.731

9.  Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts.

Authors:  Natsuko Kakudo; Tatsuya Minakata; Toshihito Mitsui; Satoshi Kushida; Frederik Zefanya Notodihardjo; Kenji Kusumoto
Journal:  Plast Reconstr Surg       Date:  2008-11       Impact factor: 4.730

10.  Effect of platelet-rich plasma on the biologic activity of the human rotator-cuff fibroblasts: A controlled in vitro study.

Authors:  Patrick Sadoghi; Birgit Lohberger; Birgit Aigner; Heike Kaltenegger; Jörg Friesenbichler; Matthias Wolf; Tarek Sununu; Andreas Leithner; Patrick Vavken
Journal:  J Orthop Res       Date:  2013-04-08       Impact factor: 3.494

View more
  2 in total

1.  In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration.

Authors:  Bronson I Pinto; Nathan D Cruz; Oscar R Lujan; Catherine R Propper; Robert S Kellar
Journal:  J Vis Exp       Date:  2019-02-23       Impact factor: 1.355

2.  AI-Driven Cell Tracking to Enable High-Throughput Drug Screening Targeting Airway Epithelial Repair for Children with Asthma.

Authors:  Alphons Gwatimba; Tim Rosenow; Stephen M Stick; Anthony Kicic; Thomas Iosifidis; Yuliya V Karpievitch
Journal:  J Pers Med       Date:  2022-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.